MYELODYSPLASTIC/MYELOPROLIFERATIVE SYNDROME INTRO Flashcards
Myelo:
bone marrow
Dysplastic:
abnormal cell devt
Proliferative:
excess production of cell
Hypercellular maturation in BM → dysplasia and cytopenia of one or more cell line
MYELODYSPLASTIC
Hypercellularity → cytosis of one cell line, usually myeloid lineage (WBCs)
MYELOPROLIFERATIVE
(uncontrolled proliferation)
MYELOPROLIFERATIVE
(effective/normal hematopoiesis but overproliferation of abnormal cells)
MYELOPROLIFERATIVE
(ineffective hematopoiesis; prominent feature)
MYELODYSPLASTIC
: tissue-producing cell
dysplasia
: ↓ circulating cells
cytopenia
↓ bm that produces the cell = ↓ blood produced = ↓ circ cells
MYELODYSPLASTIC
: ↑ circulating cells
cytosis
Hypercellular: production of blood cells (plt, rbc, wbc)
MYELODYSPLASTIC
Ex. Pronormoblast doesn’t mature to a normal mature rbc
MYELODYSPLASTIC
Cell lines: erythrocytic, megakaryocytic, myelocytic
MYELODYSPLASTIC
Predomination of apoptosis
MYELODYSPLASTIC
Proliferation outpaces apoptosis
MYELOPROLIFERATIVE
Etiology: unknown
MYELODYSPLASTIC
Etiology: mutation of gene
MYELOPROLIFERATIVE
↓ cell production
MYELODYSPLASTIC
↑ cell production
MYELOPROLIFERATIVE
Dysplasia - Ineffective hematopoiesis (bm is not produced effectively or dysplastic) = cytopenic
MYELODYSPLASTIC
Proliferation - Normal (effective) but excessive hematopoiesis with hypercellularity
MYELOPROLIFERATIVE
↑ cell death
MYELODYSPLASTIC
Rbc dies before 120 days
MYELODYSPLASTIC
Rate of apoptosis is more than the production rate of rbc
MYELODYSPLASTIC
↓cell death, ↑proliferation ≠ Homeostasis ; 1:2
MYELOPROLIFERATIVE
After 120 days, apoptotic cell increases as bm proliferates
MYELOPROLIFERATIVE
Cell proliferates priod to apoptosis = cytosis
MYELOPROLIFERATIVE
Precursor diseases prior to anemia (↓rbc) and leukemia (↓wbc)
MYELODYSPLASTIC
MYELOPROLIFERATIVE
Premalignant disease
MDS
Malignant disease
CMPD
One or more cell lines are dysplastic
MDS
All cell lines are dysplastic
CMPD
Bone marrow cellularity is slightly increased
MDS
Cellularity is markedly increased
CMPD
Peripheral cytopenia of one or more cell lines
MDS
Peripheral cytosis of one cell line
CMPD
Iron stores are often increased
MDS
Iron is normal or decreased
CMPD
No bone marrow fibrosis
MDS
Marrow fibrosis is a prominent feature
CMPD
No megakaryocyte increase in the bone marrow
MDS
Often increased numbers of megakaryocyte
CMPD
Splenomegaly is not a feature
MDS
Splenomegaly is a frequent feature
CMPD
a premalignant process (preleukemic)
MDS
a malignant disease
CMPD
one or more cell lines are dysplastic
MDS
all cell lines are malignant
CMPD
usually slightly increased
MDS
usually markedly increased
CMPD
peripheral cytopenia of one or more cell lines
MDS
peripheral cytosis of usually one cell line
CMPD
dysplasia of one or more cell lines
MDS
morphologically usually normal
CMPD
Iron stores often increased
MDS
Iron stores normal or decreased
CMPD
Bone marrow fibrosis usually none
MDS
Bone marrow fibrosis is a prominent feature in the course of disease
CMPD
Megakaryocyte population usually no increase in the bone marrow
MDS
Megakaryocyte population often increased numbers
CMPD
Splenomegaly is not a feature
MDS
Splenomegaly is not a feature but a frequent feature
CMPD
Occurs before leukemia
MDS
rbc: dysplastic
wbc, plt: normal
MDS
rbc (erythricytosis), wbc (leucocytosis), and plt (megakaryocytosis)
CMPD
incorporated in rbc to make heme
MDS
↓ rbc = is not used, but increases in the circulation
MDS
Accumulation of iron
MDS
↑cell production requires more iron
CMPD
Due to absence of cells
MDS
Cells produced inserts themselves in the sinusoids of bm esp in saturated circulation
CMPD
infiltration of cells in the bm, including the sinusoids, normal or abnormal cells
Bone marrow fibrosis
no space for circulation : very infiltrated
MDS
Enlargement of the spleen; bm compensates for the increase in plt
Splenomegaly
normal: 1/3 of plt is sequestered in the spleen
inc: accumulation in the spleen → enlargement
Splenomegaly
asynchronous cell maturation resulting to abnormal cell size
Hypercellular maturation
abnormal development of cells within tissues or organs
Dysplasia
(no cell migration to the circulation leading to cytopenia)
Dysplasia
reduction/decrease in the number of mature blood cells
Cytopenia
abnormal increase in the number of a specified type of cells
Cytosis
form of programmed cell death
Apoptosis
From a hypercellular bone marrow→ Dysplasia→ Cytopenia of one or more cell line
Myelodysplastic Syndromes
Due to predomination of apoptosis.
Myelodysplastic Syndromes
From a hypercellular bone marrow→ Cytosis of all cell line
Myeloproliferative Disorders
The proliferation outpaces apoptosis
Myeloproliferative Disorders